Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway

Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway

Abstract Background Liver cancer stem cells (LCSCs) contribute to hepatocellular carcinoma (HCC) development, metastasis, and drug resistance. MSI2 and Notch1 signaling are involved in the maintenance of CSCs. However, it is unknown whether MSI2 and Notch1 are involved in the maintenance of CD44v6+...

Full description

Bibliographic Details
Main Authors:	Xiju Wang, Ronghua Wang, Shuya Bai, Si Xiong, Yawen Li, Man Liu, Zhenxiong Zhao, Yun Wang, Yuchong Zhao, Wei Chen, Timothy R. Billiar, Bin Cheng
Format:	Article
Language:	English
Published:	BMC 2019-12-01
Series:	Journal of Experimental & Clinical Cancer Research
Subjects:	CD44 variant exon 6 Musashi2 Notch1 signaling pathway Liver cancer stem cells Hepatocellular carcinoma
Online Access:	https://doi.org/10.1186/s13046-019-1508-1

Similar Items

Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of Endometriosis
by: Theresa Strauß, et al.
Published: (2022-03-01)

RNA binding proteins in spermatogenesis: an in depth focus on the Musashi family
by: Jessie M Sutherland, et al.
Published: (2015-01-01)

CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line
by: Ryoma Asai, et al.
Published: (2019-02-01)

MSI1 Promotes the Expression of the GBM Stem Cell Marker CD44 by Impairing miRNA-Dependent Degradation
by: Rebecca Pötschke, et al.
Published: (2020-12-01)

Small Molecule Palmatine Targeting Musashi-2 in Colorectal Cancer
by: Xue Zhang, et al.
Published: (2022-01-01)

Identification and Validation of an <i>Aspergillus nidulans</i> Secondary Metabolite Derivative as an Inhibitor of the Musashi-RNA Interaction
by: Lan Lan, et al.
Published: (2020-08-01)

Musashi and Plasticity of Xenopus and Axolotl Spinal Cord Ependymal Cells
by: Ellen A. G. Chernoff, et al.
Published: (2018-02-01)

Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem Cell Characteristics and Therapy Resistance in Ovarian Cancer Cells
by: Maria T. Löblein, et al.
Published: (2021-10-01)

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
by: Jun Zhang, et al.
Published: (2021-11-01)

CD44 Expression Profile Varies According to Maturational Subtypes and Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia
by: Luísa Vieira Codeço Marques, et al.
Published: (2018-10-01)

The CD44std and CD44v9 subpopulations in non-tumorigenic invasive SNU-423 cells present different features of cancer stem cells
by: Mario Alejandro Aguilar-Chaparro, et al.
Published: (2023-10-01)

Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C<sub>44</sub>Mab-108 for Immunohistochemistry
by: Hiroyuki Suzuki, et al.
Published: (2023-02-01)

A Novel Anti-CD44 Variant 3 Monoclonal Antibody C<sub>44</sub>Mab-6 Was Established for Multiple Applications
by: Hiroyuki Suzuki, et al.
Published: (2023-05-01)

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease
by: Urmi Sengupta, et al.
Published: (2018-10-01)

Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C<sub>44</sub>Mab-3 for Multiple Applications against Pancreatic Carcinomas
by: Yuma Kudo, et al.
Published: (2023-04-01)

MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia
by: Fanfan Li, et al.
Published: (2023-05-01)

The role of Musashi protein in spermatogenesis and male infertility
by: Zohreh Talebi-Yazdabadi, et al.
Published: (2019-08-01)

Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C<sub>44</sub>Mab-34, for Multiple Applications against Oral Carcinomas
by: Hiroyuki Suzuki, et al.
Published: (2023-04-01)

Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1
by: Aliaksandr A. Yarmishyn, et al.
Published: (2020-12-01)

Expression of Musashi-1 Increases in Bone Healing
by: Miguel Padial-Molina, et al.
Published: (2021-03-01)

Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins
by: Lan Lan, et al.
Published: (2018-08-01)

Increased expression of the RNA-binding protein Musashi-2 is associated with immune infiltration and predicts better outcomes in ccRCC patients
by: Hui Li, et al.
Published: (2022-10-01)

CD44 receptor diversity and potential in preventative and regenerative therapies
by: Adam C. Midgley, et al.
Published: (2022-06-01)

Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells
by: Mahboobeh Forouzanfar, et al.
Published: (2020-05-01)

The Role of CD44 in Disease Pathophysiology And Targeted Treatment
by: Andre R. Jordan, et al.
Published: (2015-04-01)

Musashi–1—A Stemness RBP for Cancer Therapy?
by: Nadine Bley, et al.
Published: (2021-05-01)

The Musashi family RNA-binding proteins in stem cells
by: Horisawa Kenichi, et al.
Published: (2010-05-01)

The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development
by: Bruce M. Boman, et al.
Published: (2023-12-01)

Cell-type-specific control of secondary cell wall formation by Musashi-type translational regulators in Arabidopsis
by: Alicia Kairouani, et al.
Published: (2023-09-01)

Multi-modal imaging for uptake of peptide ligand specific for CD44 by hepatocellular carcinoma
by: Xiaoli Wu, et al.
Published: (2022-06-01)

The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
by: Zhenpeng Wang, et al.
Published: (2019-04-01)

Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b
by: Mahboobeh Forouzanfar, et al.
Published: (2021-02-01)

Dual Fluorescence Splicing Reporter Minigene Identifies an Antisense Oligonucleotide to Skip Exon v8 of the <i>CD44</i> Gene
by: Sachiyo Fukushima, et al.
Published: (2020-11-01)

Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation
by: Isabel Falke, et al.
Published: (2022-05-01)

Elevated N‐methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform
by: Jie Li, et al.
Published: (2019-09-01)

Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma
by: Mohammed Saeed Rozeik, et al.
Published: (2017-07-01)

Musashi-2 Deficiency Triggers Colorectal Cancer Ferroptosis by Downregulating the MAPK Signaling Cascade to Inhibit HSPB1 Phosphorylation
by: Xiaole Meng, et al.
Published: (2023-12-01)

Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
by: Ingrīda Čēma, et al.
Published: (2021-11-01)

Musashi-1 Regulates MIF1-Mediated M2 Macrophage Polarization in Promoting Glioblastoma Progression
by: Yi-Ping Yang, et al.
Published: (2021-04-01)

The RNA-Binding Protein Musashi1 Regulates a Network of Cell Cycle Genes in Group 4 Medulloblastoma
by: Mirella Baroni, et al.
Published: (2021-12-01)